Ignite Creation Date:
2025-12-25 @ 3:08 AM
Ignite Modification Date:
2026-03-08 @ 4:12 AM
Study NCT ID:
NCT02525133
Status:
COMPLETED
Last Update Posted:
2021-01-08
First Post:
2015-08-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 3 Study of Efficacy and Safety of the XaraColl® Bupivacaine Implant After Hernioplasty
Sponsor:
Innocoll
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-09-05
Start Date Type:
None
Primary Completion Date:
2016-04-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-04-22
Completion Date Type:
ACTUAL
First Submit Date:
2015-08-12
First Submit QC Date:
None
Study First Post Date:
2015-08-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-09-22
Results First Submit QC Date:
None
Results First Post Date:
2021-01-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-01-06
Last Update Post Date:
2021-01-08
Last Update Post Date Type:
ACTUAL